Peripheral artery disease: vizsgálatok itt: Ausztria
10 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 14.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA contrast medium sparing strategy using automated Carbon Dioxide Injection during PERIpheral vascular interventions for PREVENTion of Major Adverse Kidney Events (MAKE): the PeriPREVENT randomized controlled trial
- Where
- Innsbruck, Vienna
- Életkor
- 18 év and over
- People
- 1960 worldwide
- Run by
- Universitaet Leipzig
See details and how to join2024-512876-37-00 - 3. fázisNot yet taking people in AusztriaReducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
- Where
- Graz
- Életkor
- 18 év and over
- People
- 7050 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07318610 · EU 2025-522954-37-00 - No phaseTaking peopleVessel Recoil in Specific CLTI Populations
- Where
- Graz
- Életkor
- 18 év and over
- People
- 40
- Run by
- Medical University of Graz
See details and how to joinNCT07465627 - 2/3. fázisTaking peopleCombined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Where
- Vienna
- Életkor
- 18 év and over
- People
- 3110 worldwide
- Run by
- CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00 - 4. fázisTaking peopleEarly TRIPLE versus dual LIPID lowering treatment in peOple with atherosclerotic cardiovascular disease and hypercholesterolemia Undergoing elecTive revascularisation
- Where
- Feldkirch, Graz, Klagenfurt Am Woerthersee
- Életkor
- 18 év and over
- People
- 160 worldwide
- Run by
- Medical University Of Graz
See details and how to join2026-525917-29-00 - No phaseTaking peopleSELUTION4BTK Trial
- Where
- Graz
- Életkor
- 18 év and over
- People
- 376 worldwide
- Run by
- M.A. Med Alliance S.A.
See details and how to joinNCT05055297 - No phaseTaking peopleInitial Feasibility Study of the STENTiT Resorbable Fibrillated Scaffold (RFS). The RFS is Intended to Restore Lumen Patency and Blood Flow to Infrapopliteal Arteries. The RFS is a Fully Electrospun Tubular Device With a Fibrillated Microarchitecture and Designed for Transcatheter Delivery
- Where
- Graz
- Életkor
- 18 év and over
- People
- 10
- Run by
- Stentit
See details and how to joinNCT07006467 - No phaseTaking peopleProspective, Multicenter, Single-Arm Observational Study to Confirm the Safety and Clinical Performance of the Oscar Peripheral Multifunctional Catheter for the Dilatation of Lesions in the Femoral, Popliteal and Infrapopliteal Arteries (BIO-OSCAR First)
- Where
- Graz
- Életkor
- 18 év and over
- People
- 200 worldwide
- Run by
- Biotronik AG
See details and how to joinNCT06758921 - No phaseTaking peopleStudy of the R3 Vascular Drug-Eluting Bioresorbable Scaffold in Treating Below the Knee Arterial Disease
- Where
- Graz
- Életkor
- 18 év to 90 év
- People
- 30 worldwide
- Run by
- R3 Vascular Inc.
See details and how to joinNCT04912323 - No phaseTaking peopleFRAMED Infrainguinal Venous Bypass Versus Conventional Autologous Bypass Trial
- Where
- Salzburg
- Életkor
- 18 év and over
- People
- 110
- Run by
- Paracelsus Medical University
See details and how to joinNCT06082466